Compare TEVA & OTIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | OTIS |
|---|---|---|
| Founded | 1901 | 1853 |
| Country | Israel | United States |
| Employees | 32842 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7B | 30.9B |
| IPO Year | N/A | 2019 |
| Metric | TEVA | OTIS |
|---|---|---|
| Price | $29.66 | $77.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 8 |
| Target Price | $37.38 | ★ $104.13 |
| AVG Volume (30 Days) | ★ 6.7M | 3.4M |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.50 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.48 |
| Revenue Next Year | $2.51 | $4.86 |
| P/E Ratio | $28.19 | ★ $22.45 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.47 | $77.74 |
| 52 Week High | $37.35 | $105.95 |
| Indicator | TEVA | OTIS |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 29.21 |
| Support Level | $28.38 | N/A |
| Resistance Level | $31.99 | $90.71 |
| Average True Range (ATR) | 0.99 | 2.03 |
| MACD | -0.02 | -0.69 |
| Stochastic Oscillator | 42.11 | 1.66 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Otis is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis' founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.